Antimitotic Agents: all 5,052 studies that test it
Page 41 of 51. Open to participants first (616), then studies with results posted, then the rest; newest registration first within each.
- HERVIN: Trastuzumab and Vinorelbine in Metastatic Breast CancerCompletedNCT00401427Phase 2
- Taxotere (Docetaxel) in 1st Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell CarcinomaCompletedNCT00401323Phase 2/3
- Docetaxel and Temozolomide in Treating Patients With Metastatic CancerCompletedNCT00401180Phase 1
- Phase I Trial of Paclitaxel With PerifosineCompletedNCT00399126Phase 1
- Combination Chemotherapy in Treating Young Male Patients With Hodgkin's LymphomaCompletedNCT00398554Phase 2
- Docetaxel, Epirubicin, and Cyclophosphamide With or Without Trastuzumab in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By SurgeryStatus unknownNCT00398489Phase 2
- Capecitabine and Paclitaxel (Albumin-Stabilized Nanoparticle Formulation) in Treating Women Undergoing Surgery for Stage II or Stage III Breast CancerWithdrawnNCT00397761Phase 2/3
- Epothilone in Recurrent Glioblastoma PatientsCompletedNCT00397072Phase 2
- Safety Study of Increasing Doses of Combretastatin in Combination With Bevacizumab (Avastin) in Patients With Advanced Solid TumorsCompletedNCT00395434Phase 1
- Phase 1, Multiple Dose Study of MPC-6827 in Subjects With Refractory Solid TumorsCompletedNCT00394446Phase 1
- Multiple Dose Study of MPC-6827 in Subjects With Refractory Brain MetastasesCompletedNCT00393965Phase 1
- Topotecan, Vincristine, and Doxorubicin in Treating Young Patients With Refractory Stage 4 NeuroblastomaStatus unknownNCT00392340Phase 2
- Lapatinib and Vinorelbine in Treating Patients With Advanced Solid TumorsCompletedNCT00389922Phase 1
- Phase I, Open-Label, Dose-Escalation Study of AZD4877 in Solid TumorsCompletedNCT00389389Phase 1
- First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based TherapyCompletedNCT00389155Phase 2/3
- Pazopanib (VOTRIENT) Plus Paclitaxel (TAXOL), Pazopanib Plus Paclitaxel (TAXOL) Plus Carboplatin (PARAPLATIN), and Pazopanib Plus Paclitaxel (TAXOL) Plus Lapatinib (TYKERB)CompletedNCT00388076Phase 1
- Study of Larotaxel in Combination With Weekly Herceptin® in Patients With HER2 Positive Metastatic Breast CancerCompletedNCT00387907Phase 2
- Radiation Therapy, Bevacizumab, Paclitaxel, and Carboplatin in Treating Patients With Unresectable Stage IIIB or Stage IV Non-Small Cell Lung Cancer at High Risk for Hemoptysis Caused by BevacizumabCompletedNCT00387374Phase 2
- XRP9881 in Combination With Trastuzumab in Metastatic Breast CancerCompletedNCT00386685Phase 2
- A Phase 2 Study in Patients With Advanced Non-Small Cell Lung Cancer Using New Agents With and Without Docetaxel.WithdrawnNCT00386555Phase 2
- Epirubicin and Cyclophosphamide Followed By Docetaxel and Trastuzumab in Treating Women With HER2-Positive Stage III or Stage IV Breast CancerCompletedNCT00379015Phase 2
- Phase I Trial of Docetaxel and Low-Dose Fractionated Radiation in the Treatment of Metastatic or Recurrent NSCLCTerminatedNCT00378404Phase 1
- A Study of Gemcitabine, Epirubicin, and Paclitaxel Combination Chemotherapy Given Before Surgery to Patients With Locally Advanced Breast CancerCompletedNCT00378313Phase 2
- EndoTAG-1 / Gemcitabine Combination Therapy to Treat Locally Advanced and/or Metastatic Adenocarcinoma of the PancreasCompletedNCT00377936Phase 2
- Docetaxel Compared With Observation in Treating Patients Who Have Undergone Radical Prostatectomy for Prostate CancerStatus unknownNCT00376792Phase 3
- Safety and Efficacy of Neoadjuvant Radiochemotherapy in Adenocarcinoma of the Gastric-oesophageal JunctionCompletedNCT00374985Phase 1/2
- A Safety and Efficacy of CCRT With Paclitaxel as Adjuvant Therapy to Post-Operative Advanced Endometrial Cancer PatientsStatus unknownNCT00373620Phase 2
- AEG35156 and Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Solid TumorsCompletedNCT00372736Phase 1
- Efficacy and Safety of Imatinib and Vinorelbine in Patients With Advanced Breast CancerCompletedNCT00372476Phase 4
- Oral Colchicine Combined With Intravitreal Infusion of Dexamethasone, LMW Heparin and 5-FU for Management of Proliferative Vitreoretinopathy (PVR)Status unknownNCT00370760Phase 3
- Efficacy of Oral Colchicine in Prevention of Proliferative Vitreoretinopathy in Rhegmatogenous Retinal DetachmentStatus unknownNCT00370201Phase 3
- Bevacizumab, Paclitaxel, Carboplatin, and Radiation Therapy to the Chest in Treating Patients With Locally Advanced Non-Small Cell Lung CancerTerminatedNCT00369551Phase 1
- Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or LymphomaCompletedNCT00363272Phase 1
- A Study of the Alternative Administration of Ixabepilone and VinflunineCompletedNCT00362830Phase 1
- A Study of Vinflunine in Patients With Gastric CancerTerminatedNCT00359476Phase 2/3
- Study of BMS-275183 in Patients With Pretreated Locally Advanced or Metastatic NSCLC (Non Small Cell Lung Cancer)TerminatedNCT00359450Phase 2
- Phase II Trial of Locally Advanced/Metastatic Soft Tissue Sarcoma or Advanced/Metastatic Malignant GISTCompletedNCT00359333Phase 2
- Trial of PTK787/ZK 222584 Plus PaclitaxelTerminatedNCT00358163Phase 1
- AEG35156 and Docetaxel in Treating Patients With Solid TumorsCompletedNCT00357747Phase 1
- Oxaliplatin, Docetaxel, and Radiation Therapy in Treating Patients With Unresectable Stage II/III or Recurrent NSCLCTerminatedNCT00356941Phase 1
- A Phase 2 Study Evaluating ABT-751 in Combination With Taxotere in Advanced Non-Small Cell Lung CancerTerminatedNCT00354562Phase 1/2
- Combination Chemotherapy With or Without Surgery & Chemoradiotherapy in Patients With Malignant Pleural MesotheliomaCompletedNCT00354393Phase 2
- Ispinesib in Treating Patients With Metastatic or Unresectable Kidney CancerCompletedNCT00354250Phase 2
- Vinblastine and Carboplatin in Treating Young Patients With Newly Diagnosed or Recurrent Low-Grade GliomaCompletedNCT00352495Phase 1
- Primary Chemotherapy With Adriamycin/Cyclophosphamide(AC) vs Taxotere/Xeloda(TX) for Stage II and III Breast CancerCompletedNCT00352378Phase 3
- Carboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, Primary Peritoneal, or Carcinosarcoma CancerCompletedNCT00352300Phase 1
- ZK-Epo Given With Prednisone in Patients With Metastatic Androgen-independent Prostate CancerCompletedNCT00350051Phase 2
- Phase II Study of Weekly Paclitaxel (BMS-181339)in Patients With Advanced or Recurrent Esophageal CancerCompletedNCT00344552Phase 2
- Docetaxel in Locally Advanced Gastric AdenocarcinomaCompletedNCT00343239Phase 2
- A Safety and Efficacy of CCRT With Paclitaxel/Carboplatin as Adjuvant Therapy to Post-operative Cervical Cancer PatientsCompletedNCT00340184Phase 2
- A Study of Epothilone D in Combination With Herceptin (Trastuzumab) in Patients With HER-2 Positive Advanced or Metastatic Breast CancerCompletedNCT00337649Phase 1/2
- A Phase II Trial Neoadjuvant Paclitaxel and Cisplatin in Patients With Locally Advanced Head and Neck CancerCompletedNCT00337532Phase 2/3
- A Study of the mTOR Inhibitor Rapamycin (Rapamune, Sirolimus) in Combination With Abraxane in Advanced Solid CancersTerminatedNCT00337376Phase 1
- Randomized Clinical Trial to Evaluate the Predictive Accuracy of a Gene Expression for Stage I-II Breast CancerCompletedNCT00336791Phase 3
- Radiation Therapy, Chemotherapy, and Bevacizumab in Treating Patients With Recurrent, Unresectable or Stage III or Stage IV Non-Small Cell Lung CancerTerminatedNCT00334763Phase 2
- Pelvic IMRT With Tomotherapy in Post-Hysterectomy Endometrial Cancer PatientsCompletedNCT00334321Phase 1
- Ixabepilone in Treating Young Patients With Refractory Solid TumorsCompletedNCT00331643Phase 2
- ELDA: Elderly Breast Cancer - Docetaxel in Adjuvant TreatmentCompletedNCT00331097Phase 3
- EPO906 Plus Radiation Therapy for the Treatment of Cancer PatientsCompletedNCT00328458Phase 1
- Combination Study of a New Taxane and Capecitabine in Patients With Metastatic Breast CancerCompletedNCT00327743Phase 1/2
- Safety Study of Imexon Plus Docetaxel in Lung, Breast or Prostate Cancer PatientsCompletedNCT00327288Phase 1
- ZK-Epo Given With Carboplatin in Patients With Recurrent Ovarian CancerCompletedNCT00325351Phase 2
- Trial With Taxotere and Cisplatin in Non-operable Adrenocortical CarcinomaCompletedNCT00324012Phase 2
- Weekly Dosing of an Integrative Chemotherapy Combination to Treat Advanced Pancreatic CancerStatus unknownNCT00323583Phase 2
- CHOP and Campath-1H in Previously Untreated Aggressive T/NK-Cell LymphomasCompletedNCT00323323Phase 1
- Study of the Vascular Disrupting Agent NPI-2358 in Patients With Advanced Solid Tumors or LymphomaCompletedNCT00322608Phase 1
- Phase1b to Evaluate Safety of AMG706 in Combination With Paclitaxel or Docetaxel for Breast CancerCompletedNCT00322400Phase 1
- Carboplatin or Docetaxel in Treating Women With Metastatic Genetic Breast CancerCompletedNCT00321633Phase 2
- Combination Weekly Taxotere™ With Iressa™ /Placebo in Metastatic Breast CancerCompletedNCT00319618Phase 2
- Weekly Versus 3-Weekly Docetaxel Plus Cisplatin for Advanced NSCLCCompletedNCT00319514Phase 2
- Irinotecan and Taxotere With Radiotherapy as Preoperative Treatment in Resectable Esophageal CancerCompletedNCT00318903Phase 2
- Cisplatin and Docetaxel Plus Docetaxel and Radiotherapy With Amifostine for Squamous Cell Carcinoma of the Head and NeckCompletedNCT00318890Phase 1/2
- A Study of Paclitaxel Plus Bevacizumab in Patients With Chemosensitive Relapsed Small Cell Lung CancerCompletedNCT00317200Phase 2
- Lapatinib/Carboplatin/Paclitaxel in Previously Treated Ovarian or Breast Cancer PatientsCompletedNCT00316407Phase 1/2
- Weekly Topotecan With Docetaxel in Recurrent Small Cell Lung CancerTerminatedNCT00315211Phase 2
- Sequential vs Upfront Intensified Neoadjuvant Chemotherapy in Patients With Large Resectable or Locally Advanced Breast Cancer.CompletedNCT00314977Phase 3
- Cisplatin Induction With Paclitaxel Consolidation for Stage III-IV Epithelial Ovarian and Primary Peritoneal CancerCompletedNCT00314678Phase 2
- Randomized Ph 2 Trial Of Paclitaxel/Carboplatin /Bevacizumab + PF-3512676 And P/C/B Alone In Advanced Nonsquamous NSCLCTerminatedNCT00313768Phase 2
- Cancer Treatment Followed by Surgery for Early Stage Non-small Cell Lung CancerWithdrawnNCT00313690Phase 1/2
- Lapatinib and Paclitaxel in Treating Patients With Advanced Solid TumorsCompletedNCT00313599Phase 1
- PII Trial of Docetaxel/Prednisone w/Sargramostim for HRPCTerminatedNCT00313482Phase 2
- Evaluation of a New Agent for Treatment of Advanced Stage Breast CancerCompletedNCT00313248Phase 2
- Study of mAb 216 With Chemotherapy for Treatment of Pediatric Relapsed or Refractory B-progenitor Acute Lymphoblastic LeukemiaTerminatedNCT00313053Phase 1
- Gefitinib, Docetaxel, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung CancerCompletedNCT00310154Phase 1
- AZD2171 and Combination Chemotherapy in Treating Women With Locally Advanced Breast CancerCompletedNCT00310089Not applicable
- Gemcitabine, Paclitaxel, and Cisplatin in Treating Patients With Advanced Cancer of the UrotheliumCompletedNCT00310011Phase 2
- Vinorelbine and Bevacizumab in Treating Older Patients With Stage III or Stage IV Non-Small Cell Lung CancerCompletedNCT00309998Phase 2
- Ixabepilone Administered as an Enteric Coated Formulation.CompletedNCT00309049Phase 1/2
- Study of Vintafolide (MK-8109, EC145) for the Treatment of Recurrent or Refractory Solid Tumors (MK-8109-006, EC-FV-01)CompletedNCT00308269Phase 1
- Dose Dense Abraxane in Adjuvant Chemotherapy for Breast CancerCompletedNCT00308178Not applicable
- Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Gemcitabine in Treating Patients With Advanced Metastatic Solid TumorsCompletedNCT00307255Phase 1
- A Study to Determine the Antitumor Activity and Evaluate the Safety of MKC-1CompletedNCT00306631Phase 2
- Safety and Efficacy Study of a New Chemotherapy Agent to Treat Small Cell Lung CancerTerminatedNCT00299390Phase 2
- Chemotherapy of Elderly Patients With Non-Small-Cell Lung Cancer (NSCLC)CompletedNCT00298415Phase 3
- A Phase 1/2 Study Evaluating ABT-751 in Combination With Alimta in Advanced Non-Small Cell Lung CancerCompletedNCT00297089Phase 1/2
- Oral Vinorelbine and Cisplatin and Concurrent Radiotherapy After Induction Chemotherapy in Locally Advanced NSCLC.CompletedNCT00295672Phase 2
- Study Comparing Concomitant Docetaxel + Gemcitabine to Sequential Therapy of Docetaxel Followed by GemcitabineCompletedNCT00294385Phase 3
- Docetaxel, Prednisone, and Vatalanib in Treating Patients With Advanced Prostate CancerTerminatedNCT00293371Phase 1/2
- Docetaxel, Carboplatin, and Bevacizumab in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Can Be Removed By SurgeryTerminatedNCT00293332Phase 2
- An Open, Randomized, Multicentre, Phase II Pilot StudyCompletedNCT00293085Phase 2